XML 92 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Note 8 - Stock-based Compensation - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement [Line Items]      
Balance (in shares) 140,040 72,454 44,738
Balance, weighted-average exercise price (in dollars per share) $ 126.75 $ 265.91 $ 407.60
Granted, number (in shares) 0 77,088 36,310
Granted, weighted-average exercise price (in dollars per share) $ 0 $ 9.87 $ 44.66
Expired, number (in shares)   (610) (8,594)
Expired, weighted-average exercise price (in dollars per share)   $ 1,562.92 $ 68.48
Forfeited, number (in shares) (35,993) (8,892)  
Forfeited, weighted-average exercise price (in dollars per share) $ 20.13 $ 147.28  
Balance (in shares) 104,047 140,040 72,454
Balance, weighted-average exercise price (in dollars per share) $ 163.64 $ 126.75 $ 265.91
Options outstanding, weighted-average remaining contractual life (Year) 7 years 11 months 26 days 8 years 6 months  
Options outstanding, aggregate intrinsic value $ 0 $ 0  
Exercisable, number (in shares) 78,533 74,086  
Exercisable, weighted-average exercise price (in dollars per share) $ 211.21 $ 226.95  
Exercisable, weighted-average remaining contractual life (Year) 7 years 9 months 7 years 10 months 24 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value $ 0 $ 0  
Vested and expected to vest, shares (in shares) 104,047 140,040  
Vested and expected to vest, weighted-average exercise price (in dollars per share) $ 163.64 $ 126.75  
Vested and expected to vest, weighted-average remaining contractual life (Year) 7 years 11 months 26 days 8 years 6 months  
Vested and expected to vest, aggregate intrinsic value $ 0 $ 0